Amolyt Pharma Announces Abstracts Accepted for Presentation at the GRS Congress, ECE and ENDO LYON, France and CAMBRIDGE, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced that the company has had multiple abstracts accepted for presentation at the 10th International Congress of the Growth Hormone Research Society (GRS), which is being held May 10-11 in Stockholm, Sweden, the 26th European Congress of Endocrinology (ECE), which is being held May 11-14 in Stockholm, Sweden, and at the 2024 Endocrine Society Meeting (ENDO), which is being held June 1-4 in Boston, Massachusetts. These presentations cover both of Amolyt’s development programs, eneboparatide in Phase 3 for the treatment of hypoparathyroidism and AZP-3813 in Phase 1 for the treatment of acromegaly. Details of the presentations are as follows:
10th International Congress of the Growth Hormone Research Society (GRS) – May 10-11, Stockholm, Sweden
Format: Oral Presentation
Date: Friday, May 10, 2024
Time: 2:00-3:00 p.m. CEST
26th European Congress of Endocrinology (ECE) – May 11-14, Stockholm, Sweden
Format: Mini Satellite Symposium
Session: Industry-sponsored Mini Satellites, Room A6
Date: Sunday, May 12, 2024
Time: 9:45-10:15 a.m. CEST
Format: Oral Presentation
Session: Oral Communications 2: Calcium and Bone – Part I
Date: Sunday, May 12, 2024
Time: 2:40-3:40 p.m. CEST
Format: Oral Presentation
Session: Oral Communications 2: Calcium and Bone – Part I
Date: Sunday, May 12, 2024
Time: 2:40-3:40 p.m. CEST
Format: Oral Presentation
Session: Oral Communications 2: Calcium and Bone – Part I
Date: Sunday, May 12, 2024
Time: 2:40-3:40 p.m. CEST
Format: Rapid Communication
Session: Rapid Communications 5: Pituitary and Neuroendocrinology – Part I
Date: Monday, May 13, 2024
Time: 3:00-3:40 p.m. CEST
Poster Display: 9:40am CEST on Sunday, May 12 to 3:30pm CEST on Tuesday, May 14, 2024
Format: Poster Presentation
Date: Monday, May 13, 2024
Poster Display: 9:40 a.m.-7 p.m. CEST
Poster Presentation: 5:30-6:30 p.m. CEST
Title: Increased Bone Fragility Over Time in Women with Chronic Hypoparathyroidism: Real-world Data from the HypoparaNet Italian Cohort Format: Rapid Communication
Session: Rapid Communications 10: Calcium and Bone – Part II
Date: Tuesday, May 14, 2024
Time: 1:00-1:40 p.m. CEST
Poster Display: 9:40am CEST on Sunday, May 12 to 3:30pm CEST on Tuesday, May 14, 2024
2024 Endocrine Society Meeting (ENDO) – June 1-4, Boston, Mass.
Format: Rapid Fire/Poster Presentation
Date: Saturday, June 1, 2024
Format: Poster Presentation
Date: Sunday, June 2, 2024
Time: 12:00-1:30 p.m. EDT
Title: Increased Fragility of Bone Over Time in Female Patients with Chronic Hypoparathyroidism: Real-world Data from the Italian Cohort Format: Poster Presentation
Date: Sunday, June 2, 2024
Time: 12:00-1:30 p.m. EDT
Format: Poster Presentation
Date: Monday, June 3, 2024
Time: 12:00-1:30 p.m. EDT
Title: Eneboparatide, a Potent Stimulator of Urinary Calcium Reabsorption, Induces Prolonged Renal Cortex Retention and PTH1 Receptor Signalling Format: Oral Presentation
Date: Monday, June 3, 2024